ArticleDrug safety2025

Correction: Major Adverse Cardiovascular Events Related to JAK Inhibitors: A Disproportionality Analysis Using the WHO Global Individual Case Safety Database.

Raffaella Di Napoli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.